Stay updated on CDX-0159 in Chronic Urticaria: Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Chronic Urticaria: Clinical Trial page.

Latest updates to the CDX-0159 in Chronic Urticaria: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal regarding a clinical study on barzolvolimab for Chronic Spontaneous Urticaria, including details about the study's purpose, design, and inclusion/exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference16%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe webpage has been updated to reflect a new version (v2.14.3) and has added future dates in March 2025, while removing past dates and an outdated version (v2.14.2).SummaryDifference0.9%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to CDX-0159 in Chronic Urticaria: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Chronic Urticaria: Clinical Trial page.